“We appreciated that MEDraysintell nuclear medicine report is comprehensive and gives a worldwide view of the nuclear medicine market’s current situation and evolution, with a special focus on therapy, which has been neglected for long time in molecular nuclear medicine reports in the past. For somebody new in AAA, it has been a very good starting point in clarifying a shared vision of the nuclear diagnostic and therapeutic markets. It allowed new staff to get a global view on the situation but also to deep dive into each radionuclide, radiopharmaceuticals, companies, etc… We would recommend this report and would use MEDraysintell service again if need be.”